NCT07830589

Brief Summary

This randomized controlled trial aims to investigate the effects of adding whole-body vibration training to a conventional exercise program on postural stability and pain in painful women with hypermobility spectrum disorder. Participants are randomly allocated to conventional exercise or conventional exercise plus whole-body vibration groups and complete a 6-week supervised intervention program.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jul 2025Nov 2026

Study Start

First participant enrolled

July 3, 2025

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

September 15, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 21, 2026

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 5, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 9, 2026

Last Updated

September 23, 2026

Status Verified

September 1, 2026

Enrollment Period

1.3 years

First QC Date

September 15, 2026

Last Update Submit

September 19, 2026

Conditions

Keywords

Joint HypermobilityWhole-Body VibrationPostural StabilityBalancePainexercise

Outcome Measures

Primary Outcomes (4)

  • Change From Baseline in Mean Velocity of Postural Sway

    Static postural stability was assessed using three APDM Opal inertial measurement unit (IMU) sensors placed at the lumbar region and both feet. Mean velocity was automatically calculated by the APDM system and expressed in meters per second (m/sec). Eight conditions were assessed separately: double-leg firm surface eyes open/closed; tandem firm surface eyes open/closed; single-leg firm surface eyes open/closed; and single-leg foam surface eyes open/closed. In tandem stance, the dominant foot was in front; single-leg conditions were performed on the non-dominant leg. Lower values indicate less sway. Change = post-intervention minus baseline; negative values indicate reduced sway velocity.

    Baseline and 3 to 10 days after completion of the 6-week intervention.

  • Change From Baseline in Path Length of Postural Sway

    Static postural stability was assessed using three APDM Opal inertial measurement unit (IMU) sensors placed at the lumbar region and both feet. Path length was automatically calculated by the APDM system and expressed in meters per second squared (m/sec²). Eight conditions were assessed separately: double-leg firm surface eyes open/closed; tandem firm surface eyes open/closed; single-leg firm surface eyes open/closed; and single-leg foam surface eyes open/closed. In tandem stance, the dominant foot was in front; single-leg conditions were performed on the non-dominant leg. Lower values indicate less postural sway. Change = post-intervention minus baseline; negative values indicate reduced path length.

    Baseline and 3 to 10 days after completion of the 6-week intervention.

  • Change From Baseline in Sway Area

    Static postural stability was assessed using three APDM Opal inertial measurement unit (IMU) sensors placed at the lumbar region and both feet. Sway area was automatically calculated by the APDM system and expressed in square meters per second to the fourth power (m²/sec⁴). Eight conditions were assessed separately: double-leg firm surface eyes open/closed; tandem firm surface eyes open/closed; single-leg firm surface eyes open/closed; and single-leg foam surface eyes open/closed. In tandem stance, the dominant foot was in front; single-leg conditions were performed on the non-dominant leg. Lower values indicate less sway. Change = post-intervention minus baseline; negative values indicate reduced sway area.

    Baseline and 3 to 10 days after completion of the 6-week intervention.

  • Change From Baseline in Normalized Reach Distance on the Star Excursion Balance Test

    Dynamic postural stability was assessed with the Star Excursion Balance Test (SEBT). Reach distance was measured in the anterior, posteromedial, and posterolateral directions on both lower limbs. Three trials were performed for each direction, and the mean was normalized to the corresponding limb length: (mean reach distance / limb length) × 100. Results were expressed as % of limb length. Six values were analyzed separately: right and left anterior, posteromedial, and posterolateral reach. This is a continuous distance-based measure, with a minimum of 0% and no fixed maximum. Higher values indicate better reach performance. Change = post-intervention minus baseline; positive values indicate improvement.

    Baseline and 3 to 10 days after completion of the 6-week intervention.

Secondary Outcomes (8)

  • Change From Baseline in Isometric Muscle Strength Measured With a Hand-Held Dynamometer

    Baseline and 3 to 10 days after completion of the 6-week intervention.

  • Change From Baseline in Average Pain Intensity Assessed With the Numeric Rating Scale

    Baseline and 3 to 10 days after completion of the 6-week intervention.

  • Change From Baseline in Pressure Pain Threshold

    Baseline and 3 to 10 days after completion of the 6-week intervention.

  • Change From Baseline in Dominant-Side Handgrip Strength

    Baseline and 3 to 10 days after completion of the 6-week intervention.

  • Change From Baseline in 6-Minute Walk Distance

    Baseline and 3 to 10 days after completion of the 6-week intervention.

  • +3 more secondary outcomes

Study Arms (2)

Conventional Exercise Group

ACTIVE COMPARATOR

Participants allocated to this arm received a supervised conventional exercise program consisting of proprioceptive, core stabilization, and resistance exercises for six weeks. Exercise sessions were conducted at the Department of Physical Medicine and Rehabilitation, Koç University Hospital, under the supervision of a resident physician.

Other: Conventional Exercise Program

Conventional Exercise Plus Whole-Body Vibration Group

EXPERIMENTAL

Participants allocated to this arm received the same supervised conventional exercise program consisting of proprioceptive, core stabilization, and resistance exercises, with the addition of whole-body vibration exercises. The intervention was continued for six weeks. Exercise sessions were conducted at the Department of Physical Medicine and Rehabilitation, Koç University Hospital, under the supervision of a resident physician.

Other: Conventional Exercise ProgramDevice: Whole-Body Vibration

Interventions

A supervised exercise program consisting of proprioceptive, core stabilization, and resistance exercises was performed for six weeks. Exercises were progressively administered according to the study protocol under the supervision of a resident physician.

Conventional Exercise GroupConventional Exercise Plus Whole-Body Vibration Group

Whole-body vibration exercises were performed using a Power Plate Pro5 vibration platform in addition to the conventional exercise program. The intervention was administered as part of the supervised six-week exercise program.

Also known as: Power Plate Pro5
Conventional Exercise Plus Whole-Body Vibration Group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of hypermobility spectrum disorder (Beighton score ≥4/9)
  • Female participants aged 18-45 years
  • Presence of musculoskeletal pain for at least 3 months

You may not qualify if:

  • Pregnancy
  • Presence of a cardiac pacemaker, an implanted brain stimulator, a metal implant
  • Acute or chronic arthritis
  • Active malignancy
  • Acute infection
  • Initiation of medications that may affect proprioception or postural stability (e.g., antidepressants, antipsychotics, or hypnotics) within the previous 2 months
  • Regular exercise more than 3 days per week
  • Postmenopausal status
  • Orthopedic surgery within the previous 12 months
  • Vertigo
  • Acute painful conditions that would prevent participation in exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Koç University Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (2)

  • Mittal N, Santa Mina D, Buryk-Iggers S, Lopez-Hernandez L, Hussey L, Franzese A, Katz J, Laflamme C, McGillis L, McLean L, Rachinsky M, Rozenberg D, Slepian M, Weinrib A, Clarke H. The GoodHope Exercise and Rehabilitation (GEAR) Program for People With Ehlers-Danlos Syndromes and Generalized Hypermobility Spectrum Disorders. Front Rehabil Sci. 2021 Nov 8;2:769792. doi: 10.3389/fresc.2021.769792. eCollection 2021.

    PMID: 36188836BACKGROUND
  • Ewertowska P, Formella O, Poniatowski L, Zielinska A, Krzysztofik M, Czaprowski D. Effect of whole-body vibration on postural stability in young adults with generalized joint hypermobility: A comparative study. J Back Musculoskelet Rehabil. 2024;37(5):1363-1371. doi: 10.3233/BMR-240004.

    PMID: 38607750BACKGROUND

MeSH Terms

Conditions

Joint InstabilityPainMotor Activity

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Gökalp Utkugün, MD

    Koc University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Physical Medicine and Rehabilitation Resident

Study Record Dates

First Submitted

September 15, 2026

First Posted

September 21, 2026

Study Start

July 3, 2025

Primary Completion (Estimated)

October 5, 2026

Study Completion (Estimated)

November 9, 2026

Last Updated

September 23, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be made publicly available in order to protect participant confidentiality.

Locations